Kazia Therapeutics Limited American Depositary Shares (KZIA) is a publicly traded Healthcare sector company. As of July 28, 2026, KZIA trades at $12.46 with a market cap of $140.09M and a P/E ratio of 0.00. KZIA moved +0.00% today. Year to date, KZIA is +77.21%; over the trailing twelve months it is +24.34%. Its 52-week range spans $2.86 to $25.40. Analyst consensus is strong buy with an average price target of $28.50. Rallies surfaces KZIA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for KZIA combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $12.46 |
| Market Cap | $140.09M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $25.40 |
| 52-Week Low | $2.86 |
| Volume | 6.04K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
4 analysts cover KZIA: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $28.50.